Adam Lerner
Professor of Medicine, Pathology and Laboratory Medicine · Chobanian and Avedisian School of Medicine
Credentials: · · ·
History
- Present
Chobanian and Avedisian School of Medicine
Research
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
Nature Medicine · 2018 · 323 citations
Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A
European Journal of Immunology · 1989 · First of 3 authors · 281 citations
British Journal of Haematology · 2015 · 169 citations
9 papers
7 papers
7 papers
- MD
5 papers
4 papers
4 papers
- MD
4 papers
4 papers
Grants
- 1980–2021
Research Training in Blood Diseases and Resources
National Heart, Lung, and Blood Institute · T32
Contact PI · $4.1M · Boston University Medical Campus
- 2007–2012
Mass Spectrometry Resource for Biology and Medicine
National Center for Research Resources · P41
Project lead · $62.8K · Boston University Medical Campus
- 2005–2010
Cyclic AMP-Mediated Apoptosis in Lymphoid Malignancies
National Cancer Institute · R01
Contact PI · $1.2M · Boston Medical Center
- 2005–2009
Analysis of AND-34 in Human Breast Cancer
National Cancer Institute · R01
Contact PI · $938.4K · Boston Medical Center
Clinical trials
- 2012–2015
Everolimus in Treating Cutaneous T-cell Lymphoma
Principal investigator · Terminated · Phase 2
Adam Lerner
- 2008–2014
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Principal investigator · Completed · Phase 2
Spectrum Pharmaceuticals, Inc
- 2004–2007
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
Study chair · Terminated · Phase 1
Boston Medical Center